Jarrod Longcor
2021
In 2021, Jarrod Longcor earned a total compensation of $891.4K as Chief Operating Officer and Former Chief Business Officer at Cellectar Biosciences, a 55% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $92,409 |
---|---|
Option Awards | $414,000 |
Salary | $385,037 |
Total | $891,446 |
Longcor received $414K in option awards, accounting for 46% of the total pay in 2021.
Longcor also received $92.4K in non-equity incentive plan and $385K in salary.
Rankings
In 2021, Jarrod Longcor's compensation ranked 9,146th out of 12,415 executives tracked by ExecPay. In other words, Longcor earned more than 26.3% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 9,146 | 26th |
Manufacturing | 4,055 | 26th |
Chemicals And Allied Products | 1,786 | 25th |
Drugs | 1,588 | 24th |
Pharmaceutical Preparations | 1,181 | 24th |
Longcor's colleagues
We found three more compensation records of executives who worked with Jarrod Longcor at Cellectar Biosciences in 2021.
News
Cellectar Biosciences CEO James Caruso's 2023 pay jumps 34% to $2M
April 26, 2024
Cellectar Biosciences CEO James Caruso's 2021 pay jumps 112% to $2.2M
April 29, 2022
Cellectar Biosciences CEO James Caruso's 2020 pay rises 9% to $1M
May 13, 2021
Cellectar Biosciences CEO James Caruso's 2019 pay jumps 21% to $934K
April 28, 2020
Cellectar Biosciences CEO James Caruso's 2018 pay falls 23% to $770K
April 29, 2019